Company Filing History:
Years Active: 2012
Title: Michihiko Harada: Innovator in Anaerobic Lactic Acid Bacteria
Introduction
Michihiko Harada is a prominent inventor based in Nagano, Japan. He is known for his significant contributions to the field of microbiology, particularly in the development of therapeutic agents derived from lactic acid bacteria. His innovative work focuses on creating safe and effective solutions for diseases that thrive in anaerobic environments.
Latest Patents
Harada holds a patent for an "Obligately anaerobic mutant lactic acid bacterium and preparation method therefor, and expression vector functioning in obligately anaerobic lactic acid bacterium." This invention provides a lactic acid bacterium that poses no risk of side effects in normal tissue, making it a promising therapeutic agent and gene transporter for diseases found in anaerobic environments, such as solid tumors. The bacterium has been artificially mutated to be obligately anaerobic and can be transformed by an expression vector that introduces a gene for expressing an active protein beneficial for treatment.
Career Highlights
Harada's career is marked by his dedication to advancing medical microbiology. His work has led to the development of a highly safe and effective therapeutic agent and gene transporting microorganism, which is crucial for treating diseases in anaerobic conditions. He is affiliated with Anaeropharma Science, Inc., where he continues to innovate in this vital area of research.
Collaborations
Harada has collaborated with notable colleagues, including Shizunobu Igimi and Minoru Fujimori. Their combined expertise has contributed to the advancement of research in anaerobic bacteria and their applications in medicine.
Conclusion
Michihiko Harada's innovative work in the field of anaerobic lactic acid bacteria has the potential to revolutionize therapeutic approaches for diseases in anaerobic environments. His contributions are paving the way for safer and more effective medical treatments.